RELX Plc

NYSE:RELX

Specialty Business Services

Industrials
$39.02 -2.42%

-$0.78 today

Market cap
$67.94B
Beta
0.25
P/E (TTM)
20.7
EPS (TTM)
$1.14
Dividend yield
2.87%
52W Low $27.57High $54.37

Volume 2.35M

Average 2.83M

RELX Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

RELX PlcNYSE: RELX

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development remains negative

Q2 FY2026 research & development was £0, compared with £173M a year earlier. Over 3 fiscal years it compounded at +4.4% a year.

Context

  • Research & development amounted to 3.7% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
£0— QoQ
Last fiscal yearDec 2025
£352M-3.3% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-3.3%——
3-year CAGR+4.4%——
5-year CAGR——
10-year CAGR——

Research & Development history

GBP · from the income statement

Latest · FY2025
352M GBP
Year-over-year change
-3.3%
4-year CAGR
+4.5%

Research & Development vs competitors

How RELX compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -3.3% is the lowest of 2, against a peer median of +5.4%.
  • Research & development amounts to 3.7% of revenue for RELX, versus a peer median of 0.0%.
RELX Competitors
Research & Development for RELX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RELXRELX PlcFY2025£352M GBP-3.3%+4.4%3.7%
MSCIMSCI Inc.LTM Sep 2026$184.32M USD+5.4%+18.3%5.4%
NDAQNasdaq, Inc.LTM Sep 2026$0 USD——0.0%
TRIThomson Reuters CorporationLTM Jun 2026$0 USD——0.0%
VRSKVerisk Analytics, Inc.LTM Jun 2026$0 USD——0.0%
ULSUL Solutions Inc.LTM Jun 2026$0 USD——0.0%
CLVTClarivate PlcLTM Mar 2026$0 USD——0.0%
Peer median (excluding RELX) —+5.4%+18.3%0.0%

Competitors are the stored peer set for RELX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

GBP
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue7.24B8.55B9.16B9.43B9.59B
Cost of Revenue2.56B3.05B3.22B3.3B3.23B
Gross Profit4.68B5.51B5.95B6.13B6.36B
Gross Margin64.6%64.4%64.9%65.0%66.3%
Research & Development295M309M330M364M352M
Selling, General & Admin2.83B3.2B3.31B3.32B3.37B
Operating Expenses2.83B3.2B3.26B3.27B3.33B
Depreciation & Amortization724M785M717M292M735.52M
EBITDA2.65B3.06B3.31B3.13B3.72B
EBITDA Margin36.5%35.8%36.2%33.2%38.8%
Operating Income1.88B2.32B2.68B2.86B2.98B
Operating Margin26.0%27.2%29.3%30.3%31.1%
Interest Income8M4M7M9M11.74M
Interest Expense150M205M300M281M291.47M
Other Income / Expenses(87M)(229M)(387M)(304M)(233M)
Income Before Tax1.8B2.09B2.3B2.56B2.75B
Pre-Tax Margin24.8%24.5%25.1%27.1%28.7%
Income Tax Expense326M481M507M613M672M
Net Income1.47B1.63B1.78B1.93B2.07B
Net Margin20.3%19.1%19.4%20.5%21.5%
EPS (Basic)0.760.850.941.031.13
EPS (Diluted)0.760.850.941.031.12
Weighted Avg Shares1.93B1.92B1.9B1.88B1.83B
Weighted Avg Shares (Diluted)1.94B1.93B1.9B1.88B1.84B

RELX Plc

NYSE:RELX

Intrinsic Alpha fair value

Locked

Current Price

$39.02

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.